Cardamom — Benefits Deep Dive

Green cardamom — Elettaria cardamomum, the small pale pods of masala chai, Gulf coffee and Scandinavian bun dough — carries more health claims than almost any other spice on the rack, and a modern trial record you could read in an afternoon. These four pages take the four claims people actually search for and go through each one at the level of the individual study: who was enrolled, how many, for how long, against what comparison, and what changed.

A note on species before anything else. Two unrelated spices are sold as "cardamom." Green or true cardamom is Elettaria cardamomum, in the ginger family, and it is the only plant these pages are about. Black or large cardamom is Amomum subulatum — a different genus, dried over wood fires, smoky rather than sweet, with its own separate and much thinner research literature. A study on one tells you nothing reliable about the other, and marketing copy conflates them constantly.

A note on how thin the human evidence is. The randomized trials of green cardamom number in the single digits. Most were run in Iran, in two specific populations: overweight or obese adults with ultrasound-confirmed non-alcoholic fatty liver disease, and adults with type 2 diabetes. The most-quoted blood-pressure study enrolled twenty people with newly diagnosed stage 1 hypertension and had no control group at all. Cardamom's oldest and most confident claim — that it settles the stomach — has no randomized trial behind it whatsoever, only animal work and a thousand years of practice. All of that is stated plainly on the pages below rather than smoothed into a summary, and every claim is labelled by evidence tier: randomized clinical trial, preliminary (animal, isolated tissue or cell culture), or traditional use only.

What survives that scrutiny is still worth knowing. There is a consistent trial dose — three grams a day of green cardamom powder, which is a heaped teaspoon and an entirely ordinary amount for a household that cooks with the spice. There is a reproducible signal on triglycerides and on a few inflammatory markers. There is real pharmacology behind the digestive tradition even without the trials. And there is one documented reason for caution that gets left out of most write-ups: an increase in fibrinolytic activity, which matters if you take an anticoagulant.

Deep-Dive Articles

Table of Contents

1. Deep-Dive Articles
2. How to Read the Evidence Here
3. The Dose Used in the Trials
4. Key Research: Digestion and the Gut
5. Key Research: Oral Health and Breath
6. Key Research: Blood Pressure and Vessels
7. Key Research: Metabolic and Liver Outcomes
8. Key Research: Chemistry, Safety and Reviews
9. External Resources
10. Safety and Disclaimer
11. Connections

How to Read the Evidence Here

Three tiers appear throughout these pages, and the difference between them is the difference between a fact and a hope.

1. Randomized clinical trial. Humans, randomly assigned, ideally with a placebo group and blinding. Green cardamom has a handful of these — enough to say something narrow and defensible, not enough to say something sweeping.
2. Preliminary. Animal studies, isolated strips of gut or artery, cell cultures, chemical assays in a test tube. Almost all of cardamom's mechanistic story sits here. This tier tells you what could happen at concentrations a laboratory chooses; it does not tell you what happens when you drink chai.
3. Traditional use only. Recorded practice over centuries in Ayurveda, Unani medicine and Arab and Persian custom. It is evidence that people found something worth repeating. It is not evidence of a mechanism or a magnitude, and it is silent about the times it did not work.

Two habits of the supplement literature are worth watching for, because both apply directly to cardamom. The first is compound substitution: 1,8-cineole, one of cardamom's two dominant volatiles, is a genuinely well-studied drug in its own right, with placebo-controlled respiratory trials behind purified preparations. That research belongs to the isolated molecule at a therapeutic dose, not to a spice pod, and quoting it as cardamom evidence is a sleight of hand. The second is cohort reuse: a single well-run trial can generate four or five separate publications from the same participants, which makes a search result list look like an evidence base when it is one study wearing several hats.

The Dose Used in the Trials

One number recurs across essentially every human study of green cardamom: 3 grams per day of green cardamom powder, split into two or three doses taken with meals, for eight to twelve weeks. The hypertension study used it. The fatty-liver trials used it, delivered as two 500 mg capsules three times daily. The type 2 diabetes work used it. Because the figure is consistent, it is the only evidence-anchored quantity available — and it is worth appreciating how ordinary it is. Three grams is roughly a heaped teaspoon of ground seed, or the seeds from somewhere around twenty-five to thirty pods. A South Indian or Gulf kitchen can reach that in a day without trying.

What no trial supports is a therapeutic dose for any named condition, because the trial base is too small to establish one, and no study has compared doses. Higher is not better here; it is simply untested.

Key Research: Digestion and the Gut

1. Gilani AH, Jabeen Q, Khan AU, Shah AJ. Gut modulatory, blood pressure lowering, diuretic and sedative activities of cardamom. Journal of Ethnopharmacology, 2008. The single most useful mechanistic paper on cardamom: isolated tissue and rodent work showing both spasmolytic and cholinergic gut effects, plus the diuretic and sedative findings. Find on PubMed — preliminary.
2. Jamal A, Javed K, Aslam M, Jafri MA. Gastroprotective effect of cardamom, Elettaria cardamomum Maton. fruits in rats. Journal of Ethnopharmacology, 2006. Cardamom fruit extracts reduced experimentally induced gastric lesions in rats. Find on PubMed — preliminary.
3. Cardamom and gastrointestinal smooth muscle — the wider antispasmodic literature on cardamom and its volatiles.
4. Zingiberaceae spices as carminatives in dyspepsia — the family context, where ginger has the human trials cardamom lacks.

Key Research: Oral Health and Breath

1. Noumi E, Snoussi M, Alreshidi MM, et al. Chemical and biological evaluation of essential oils from cardamom species. Molecules, 2018. Composition analysis alongside antimicrobial testing of cardamom essential oils. Find on PubMed — preliminary, in vitro.
2. Cardamom extracts against Streptococcus mutans — culture-dish work on the main caries organism.
3. Halitosis, volatile sulfur compounds and tongue coating — what actually causes bad breath, which is the context any spice claim has to fit into.
4. Essential-oil mouthrinses in randomized plaque and gingivitis trials — the standard cardamom would have to be measured against, and has not been.

Key Research: Blood Pressure and Vessels

1. Verma SK, Jain V, Katewa SS. Blood pressure lowering, fibrinolysis enhancing and antioxidant activities of cardamom (Elettaria cardamomum). Indian Journal of Biochemistry and Biophysics, 2009. Twenty adults with newly diagnosed stage 1 hypertension, 3 g/day for twelve weeks, no control group. Find on PubMed — uncontrolled human pilot study.
2. Cardamom and blood pressure, randomized controlled trials — run this search yourself; the shortage of results is the finding.
3. Cardamom, fibrinolytic activity and platelets — the basis of the anticoagulant caution.
4. Regression to the mean in uncontrolled blood-pressure studies — why a single-arm hypertension study almost always looks positive.

Key Research: Metabolic and Liver Outcomes

1. Daneshi-Maskooni M, Keshavarz SA, Qorbani M, et al. Green cardamom increases Sirtuin-1 and reduces inflammation in overweight or obese patients with non-alcoholic fatty liver disease: a double-blind randomized placebo-controlled clinical trial. Nutrition & Metabolism (London), 2018. Eighty-seven adults, 3 g/day for three months. Find on PubMed — randomized clinical trial.
2. Daneshi-Maskooni M, Keshavarz SA, Qorbani M, et al. Green cardamom supplementation improves serum irisin, glucose indices, and lipid profiles in overweight or obese non-alcoholic fatty liver disease patients. BMC Complementary and Alternative Medicine, 2019. A companion report from the same participants. Find on PubMed — randomized clinical trial, same cohort.
3. Aghasi M, et al. Beneficial effects of green cardamom on serum SIRT1, glycemic indices and triglyceride levels in patients with type 2 diabetes mellitus: a randomized double-blind placebo-controlled clinical trial. Journal of the Science of Food and Agriculture, 2019. Find on PubMed — randomized clinical trial.
4. Asbaghi O, Eslampour E, Reiner Ž, et al. Effect of green cardamom on lipoproteins, glycemic control and anthropometric parameters: a meta-analysis of randomized clinical trials. Clinical Nutrition ESPEN, 2020. Seven pooled trials. Find on PubMed — meta-analysis of randomized trials.
5. Cardamom and non-alcoholic fatty liver disease — the full set of publications from this line of work, useful for spotting cohort reuse.

Key Research: Chemistry, Safety and Reviews

1. Ashokkumar K, Murugan M, Dhanya MK, Warkentin TD. Botany, traditional uses, phytochemistry and biological activities of cardamom [Elettaria cardamomum (L.) Maton] — a critical review. Journal of Ethnopharmacology, 2020. The best single entry point to the chemical literature. Find on PubMed — review.
2. 1,8-Cineole (eucalyptol) in randomized placebo-controlled trials — the isolated-compound literature, deliberately kept separate from the spice.
3. α-Terpinyl acetate pharmacology — cardamom's other dominant volatile, far less studied than cineole.
4. Cardamom and cytochrome P450 drug interactions — laboratory enzyme work behind the concentrated-extract caution.
5. Amomum subulatum (black cardamom) — the separate literature of the other spice, listed here so it is never mistaken for this one.

External Resources

• PubMed — all indexed literature on Elettaria cardamomum. The primary source for everything on these pages.
• Memorial Sloan Kettering — About Herbs database. Independently written herb monographs with an explicit interactions section, aimed at people on medication.
• National Center for Complementary and Integrative Health. US government reviews of herb and supplement evidence.
• USDA FoodData Central. Nutrient composition of ground cardamom, including its unusually high manganese content by weight.
• Kew — Plants of the World Online. Authoritative botanical records for Elettaria and Amomum, if you want to confirm the species distinction yourself.
• Spices Board India. Grading, origin and quality standards for cardamom in trade — relevant because adulteration of an expensive spice is common.

Safety and Disclaimer

Cardamom is very well tolerated. It has a long global history of daily culinary use, and the trials at 3 grams a day for up to three months reported no significant adverse effects. Three cautions are nonetheless real and specific. If you take warfarin, a direct oral anticoagulant or high-dose aspirin, stay at culinary amounts — the 2009 hypertension study reported increased fibrinolytic activity, and although that is a single uncontrolled finding, the downside of ignoring it is a bleed. If you have known gallstones, keep to food quantities; cardamom is traditionally regarded as a mild stimulant of bile flow, and stimulating a stone-bearing gallbladder can provoke colic. If you are pregnant, culinary use is safe and universal across South Asia and the Middle East, but gram-level therapeutic doses have not been studied. Stop concentrated cardamom supplements about two weeks before planned surgery. People allergic to other members of the ginger family should introduce cardamom carefully.

This page is educational and is not medical advice. Nothing here should displace treatment for hypertension, diabetes, raised triglycerides or fatty liver disease, and no spice is a substitute for a prescribed medicine. Persistent digestive symptoms, persistent bad breath and uncontrolled blood pressure all need a diagnosis rather than a seasoning. Talk to your doctor or pharmacist before adding gram-level doses of anything to a medication regimen.

Connections

• All Herbs
• Cardamom (Elettaria cardamomum) — the main topic page: botany, green versus black, names, origins, culinary technique.
• Cardamom for Digestive Health — the carminative tradition and the missing trials.
• Cardamom for Oral Health and Fresh Breath — masking versus antibacterial action.
• Cardamom for Blood Pressure and Heart Health — one small uncontrolled study, examined closely.
• Cardamom's Metabolic and Antioxidant Effects — the fatty-liver and diabetes trials.
• Ginger — Benefits — cardamom's close relative, and the Zingiberaceae member that actually has nausea trials.
• Cinnamon — Benefits — the other warm spice with a glucose literature, and the same replication problems.
• Fennel — Benefits — the other classic after-meal carminative seed.
• Clove — Benefits — shares the chai pot and has the stronger oral-health evidence.
• Coriander Seeds — a fellow digestive spice in the same masala.
• Functional Dyspepsia — the condition cardamom is most often reached for.
• Hypertension — what actually moves blood pressure, in context.
• Non-Alcoholic Fatty Liver Disease — the population in cardamom's best-designed trial.
• Type 2 Diabetes — the other trial population.
• Lipid Panel — where a triglyceride change would show up.
• Manganese — the mineral cardamom is unusually rich in by weight.

Back to Table of Contents